« Back to Record
Citation APA

Awada, A., Eskens, F. A., Piccart-Gebhart, M., Cutler, D. L., van der Gaast, A., Bleiberg, H., Wanders, J., Faber, M., Statkevich, P., Fumoleau, P., & Verweij, J. (2002). Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours. European journal of cancer, 38(17), 2272-2278. doi:10.1016/S0959-8049(02)00379-9


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/84199

Awada, A., Eskens, F. A., Piccart-Gebhart, M., Cutler, D. L., van der Gaast, A., Bleiberg, H., Wanders, J., Faber, M., Statkevich, P., Fumoleau, P., & Verweij, J. (2002). Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours. European journal of cancer, 38(17), 2272-2278. doi:10.1016/S0959-8049(02)00379-9